News

Filter

Current filters:

tiotropium

1 to 9 of 79 results

FDA panel recommends Boehringer drug for the maintenance treatment of COPD

FDA panel recommends Boehringer drug for the maintenance treatment of COPD

15-08-2014

There was good news late yesterday for German family-owned pharma major Boehringer Ingelheim, when an…

Boehringer IngelheimPharmaceuticalRegulationRespiratory and PulmonarySpirivatiotropiumUS Food and Drug AdministrationUSA

First Ph III data on Boehringer’s fixed-dose combo tiotropium plus olodaterol in COPD

22-05-2014

German family-owned drug major Boehringer Ingelheim has presented positive results of the VIVACITO (NCTO1559116)…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and Pulmonarytiotropium

New Ph III data show tiotropium Respimat effective across asthma severities

03-03-2014

German family-owned drug major Boehringer Ingelheim has released new data from large scale, Phase III…

Boehringer IngelheimPharmaceuticalResearchRespimatRespiratory and Pulmonarytiotropium

Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma patients

25-02-2013

German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III…

Boehringer IngelheimPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

Boehringer reveals new data on olodaterol and tiotropium combo at ERS

04-09-2012

German family-owned drug major Boehringer Ingelheim for the first time presented data from a Phase II…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

COPD market to grow to more than $13.4 billion in 2020

19-12-2011

As a result of an expanding aging population, increases in drug treatment and the uptake of premium priced…

Boehringer IngelheimGlobalMarkets & MarketingolodaterolPharmaceuticalRespiratory and Pulmonarytiotropium

1 to 9 of 79 results

COMPANY SPOTLIGHT

Menarini

Back to top